Telos Capital Management Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 25,865 shares of the exchange traded fund’s stock after selling 535 shares during the quarter. Telos Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were […] Read this story